[go: up one dir, main page]

DK3430162T3 - Methyleringsmarkører for pankreascancer - Google Patents

Methyleringsmarkører for pankreascancer Download PDF

Info

Publication number
DK3430162T3
DK3430162T3 DK17712443.5T DK17712443T DK3430162T3 DK 3430162 T3 DK3430162 T3 DK 3430162T3 DK 17712443 T DK17712443 T DK 17712443T DK 3430162 T3 DK3430162 T3 DK 3430162T3
Authority
DK
Denmark
Prior art keywords
pancreatic cancer
methylation markers
methylation
markers
pancreatic
Prior art date
Application number
DK17712443.5T
Other languages
English (en)
Inventor
Henrik Krarup
Ole Thorlacius-Ussing
Stine Dam Henriksen
Poul Madsen
Original Assignee
Region Nordjylland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Region Nordjylland filed Critical Region Nordjylland
Application granted granted Critical
Publication of DK3430162T3 publication Critical patent/DK3430162T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK17712443.5T 2016-03-18 2017-03-17 Methyleringsmarkører for pankreascancer DK3430162T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16161073 2016-03-18
PCT/EP2017/056393 WO2017158158A1 (en) 2016-03-18 2017-03-17 Methylation markers for pancreatic cancer

Publications (1)

Publication Number Publication Date
DK3430162T3 true DK3430162T3 (da) 2022-09-19

Family

ID=55586210

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17712443.5T DK3430162T3 (da) 2016-03-18 2017-03-17 Methyleringsmarkører for pankreascancer

Country Status (5)

Country Link
US (2) US20200095640A1 (da)
EP (1) EP3430162B1 (da)
DK (1) DK3430162T3 (da)
ES (1) ES2927505T3 (da)
WO (1) WO2017158158A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202019005627U1 (de) * 2018-04-02 2021-05-31 Grail, Inc. Methylierungsmarker und gezielte Methylierungssondenpanels
JP7733581B2 (ja) * 2019-05-29 2025-09-03 ユニヴェルシテ・パリ・シテ 膵臓癌を診断するための高メチル化遺伝子の検出
KR102289278B1 (ko) * 2019-07-09 2021-08-13 주식회사 베르티스 췌장암 진단용 바이오마커 패널 및 그 용도
CN112301125A (zh) * 2019-07-30 2021-02-02 立森印迹诊断技术(无锡)有限公司 一种肿瘤标志物及其应用
US20230221322A1 (en) * 2020-06-03 2023-07-13 Public University Corporation Yokohama City University Method and reagent for detecting pancreatic cancers
CN113186282B (zh) * 2021-04-29 2022-10-25 北京艾克伦医疗科技有限公司 鉴定胰腺癌状态的方法和试剂盒
KR102549013B1 (ko) * 2022-10-11 2023-06-28 주식회사 엔도믹스 췌장암 진단을 위한 메틸화 마커 유전자 및 이의 용도
CN117344014B (zh) * 2023-07-19 2024-06-28 上海交通大学医学院附属瑞金医院 一种胰腺癌早期诊断试剂盒、方法及其装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007524369A (ja) * 2003-03-17 2007-08-30 ザ ジョンズ ホプキンス ユニバーシティー 膵癌における異常メチル化遺伝子
US20080261217A1 (en) * 2006-10-17 2008-10-23 Melnikov Anatoliy A Methylation Profile of Cancer
EP2102361B1 (en) * 2006-11-20 2015-07-08 The Johns Hopkins University Dna methylation markers and methods of use

Also Published As

Publication number Publication date
EP3430162A1 (en) 2019-01-23
EP3430162B1 (en) 2022-06-29
US20210222256A1 (en) 2021-07-22
US20200095640A1 (en) 2020-03-26
WO2017158158A1 (en) 2017-09-21
ES2927505T3 (es) 2022-11-07

Similar Documents

Publication Publication Date Title
IL280521A (en) Methylated markers for colorectal cancer
HUE060078T2 (hu) CDK7 gátlására alkalmas vegyületek
DK3445767T3 (da) Makrocykliske mcl1-inhibitorer til behandling af cancer
EP3481953A4 (en) SPECIFIC METHYLATION MARKERS OF LIVER CANCER AND USES THEREOF
DK3234184T3 (da) Fremgangsmåder til detektering af cpg-methylering og til diagnosticering af cancer
DK3371171T3 (da) Inhibitorer af RET
DK3430162T3 (da) Methyleringsmarkører for pankreascancer
IL256018A (en) Audible indicator
EP3402517A4 (en) Immunologic treatment of cancer
PT3283527T (pt) Terapêutica de combinação para o cancro
DK3241026T3 (da) Fremgangsmåde til absolut kvantificering af naturligt forarbejdede hla-begrænsede cancerpeptider
DK3377516T3 (da) Sammensætning til behandling af cancer
EP3310905C0 (en) CELLULAR TARGETED LABEL DELIVERY SYSTEM
DK3186244T3 (da) Dioxolananaloger af uridin til behandling af cancer
DK3622953T3 (da) Kombinationsbehandling af cancer
LT3303715T (lt) Išskleidžiama slėptuvė
PT3353168T (pt) Compostos e métodos para inibir jak
DK3117216T3 (da) Fremgangsmåde til detektering af en solid tumor-cancer
DK3371165T3 (da) Btk-inhibitor til anvendelse til behandling af kræft
SG11201706223VA (en) Biomarkers for pancreatic cancer
DK3143026T3 (da) Forbindelser og sammensætninger til induktion af chondrogenese
DK3303616T3 (da) Fremgangsmåder til prognose af prostatakræft
PT3457851T (pt) Derivados de sobetiroma
EP3593139C0 (en) CANCER BIOMARKERS
IL264589A (en) Combination therapy for the treatment of pancreatic cancer